CAAP Company: Conavi Medical Announces Health Canada Approval

Ontario Industry Updates
Written By obio

Former OBIO CAAP company Conavi Medical, has announced Health Canada approval of the Foresight Intracardiac Echocardiography (ICE) System™.

Conavi's advanced technology platform is now available to Canadian physicians performing minimally invasive cardiovascular procedures that treat atrial fibrillation, structural heart disease and other cardiac conditions.

Read the full Press Release HERE

obio
Previous

CAAP Company: CellAegis Devices Announces US$9.5 Million Financing

Next

Pre-CAAP Company: MedStack Joins OBIO as a New Benefit Provider